KRAS and the related members of the RAS family are mutated in nearly 50% of human cancers, and hence it would be expected that if RAS expression or function is modulated by circadian clock disruption, then clock gene mutations or chronic shift work would affect RAS signaling and its potential mutagenic effects. This evidence concerns the gene CLOCK and cancer.